Briacell Therapeutics
Price & Volume
Stats
See more52W Range | $6-$190.50 |
Market Cap | $19.4M |
Shares Short | 13,767 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$76.90 |
News
See moreYahoo Finance • last month
BriaCell’s Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal
Yahoo Finance • last month
BriaCell to implement 1-for-10 reverse stock split to maintain Nasdaq listing
Yahoo Finance • last month
BriaCell Announces Proposed Effective Date of Share Consolidation
Yahoo Finance • 2 months ago
BriaCell Selected for MSK’s 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer
About
CEO | Dr. William V. Williams FCPA, M.D. |
CFO | Mr. Gadi Levin B.Com., C.A., CPA, M.B.A. |
Address | Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
